Houston, TX USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Older Women with Breast Cancer Report Better Cosmetic Satisfaction with Less Radiation, Less Surgery


In the first study evaluating patient-reported cosmetic outcomes in a population-based cohort of older women with breast cancer, The University of Texas MD Anderson Cancer Center researchers found that less radiation was associated with improved...
9-Dec-2016 12:05 PM EST Add to Favorites

Image-Guided Biopsy Identifies Patients Who Achieve Pathologic Complete Response After Neoadjuvant Therapy


In a pilot study conducted at The University of Texas MD Anderson Cancer Center, image-guided biopsies identified select breast cancer patients who achieved pathologic complete response (pCR) after chemotherapy and/or targeted therapy, neoadjuvant...
9-Dec-2016 11:05 AM EST Add to Favorites

Nivolumab with Chemotherapy Improves Response, Survival in AML Study Patients


The immunotherapy drug nivolumab in combination with standard chemotherapy more than doubled response rates and improved overall survival in patients with acute myeloid leukemia (AML), according to preliminary findings by researchers at The...
1-Dec-2016 11:05 AM EST Add to Favorites

Childhood Cancer Leader Joins MD Anderson to Lead Pediatrics


Richard Gorlick, M.D., an internationally recognized expert in pediatric oncology and hematology, today joined The University of Texas MD Anderson Children’s Cancer Hospital as the division head and department chair of Pediatrics.
5-Dec-2016 10:15 AM EST Add to Favorites

Research Shows Patients Ineligible for Studies May Benefit From Trial Participation


Patients who potentially could benefit most from participation in clinical trials due to poor prognoses often are not included based on eligibility criteria, such as existing medical illnesses.
1-Dec-2016 11:05 AM EST Add to Favorites

Biomarker May Predict Which Formerly Treated Cancer Patients Will Develop Highly Fatal Form of Leukemia


Patients successfully treated for breast, colon and other cancers can go on to develop an often-fatal form of leukemia, sometimes years after completion of treatment, due to a genetic mutation leading to secondary malignancies known as...
1-Dec-2016 10:05 AM EST Add to Favorites

Research Reveals Insight Into How Lung Cancer Spreads


A cellular component known as the Golgi apparatus may play a role in how lung cancer metastasizes, according to researchers at The University of Texas MD Anderson Cancer Center whose findings were reported in the Nov. 21 online issue of the Journal...
21-Nov-2016 2:05 PM EST Add to Favorites

Seven MD Anderson Faculty Elected as AAAS Fellows

In recognition of wide-ranging contributions to the fields of cancer prevention, patient care, and basic, translational, and clinical research, seven faculty members from The University of Texas MD Anderson Cancer Center have been named Fellows of...
21-Nov-2016 10:35 AM EST Add to Favorites

Our Experts on Newswise

Mastectomy Plus Reconstruction Has Highest Rate of Complication, Complication-Related Costs of Guideline-Concordant Therapies for Early Breast Cancer


In a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had the highest rate of complications and complication-related costs, regardless of age.
27-Sep-2016 3:05 PM EDT

Can Gender Play a Role in Determining Cancer Treatment Choices?


It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular level has been poorly understood.
9-May-2016 12:00 PM EDT

MD Anderson Study Reveals New Insight Into Tumor Progression


Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT

Poor Survival Among Colorectal Cancer Patients Tied to Biomarker CSN6


A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT

MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System


The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT

MD Anderson Joins CATCH Global Foundation to Boost Child Health, Prevent Cancer in Later Years

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST

MD Anderson Energy Balance Expert Available for Obesity, Cancer Stories

30-Oct-2013 8:10 PM EDT

MD Anderson Obesity and Cancer Expert Researches Food Addiction

30-Oct-2013 8:00 PM EDT

Our YouTube Videos

Chat now!